160 likes | 237 Views
Delve into the dynamics of psychiatric drugs acting on receptors through membrane interactions. Explore the receptor antagonist hypothesis and transmitter drug blockade mechanism, examining the tight coupling of metabolites in the polyphosphoinositide cycle. Gain insights into the intercalation of drugs like chlorpromazine in membranes with simulations and micelle studies. Uncover the significance of drug-membrane interactions in psychiatric pharmacology.
E N D
DRUG-MEMBRANE INTERACTIONSHolm Holmsen Department of Biomedicine, UoB
ACTION OF PSYCHIATRIC DRUGS A. The RECEPTOR ANTAGONIST Hypothesis TRANSMITTER DRUG (Blockade) RECEPTOR RECEPTOR SIGNAL
Tight coupling of phosphorylated metabolites in PPI cycle 32P-labelled platelets, [thrombin]var, ,[thrombin]const/[hirudin]var
+CPZ -CPZ -CPZ +CPZ PIP/PA and PIP2/PA relationships with chlorpromazine
Prochlorperazine Trifluoperazine
Quietiapine Haloperidol
Pimozide Clozapine
55 50 45 40 35 30 25 20 15 (ppm) Unilammelar micelles of DPPC/PBPS (70:30) +CPZ (10%) -CPZ
CPZ in 18:0/20:0 PE After simulation, >100 ps Before simulation
CPZ in 18:0/20:4 PE Before simulation After simulation, >100 ps
+ Chlorpromazine does not intercalate in SOPS
+ Chlorpromazine does intercalate in SDPS
ACTION OF PSYCHIATRIC DRUGS B. The MEMBRANE INTERCALATION Hypothesis TRANSMITTER DRUG RECEPTOR RECEPTOR RECEPTOR SIGNAL